| Tag | Content |
|---|
EnhancerAtlas ID | HS128-14486 |
Organism | Homo sapiens |
Tissue/cell | MCF-7 |
Coordinate | chr21:46317400-46318980 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MYC | MA0147.3 | chr21:46317617-46317629 | GGGCACGTGGCT | - | 6.18 | | MYC | MA0147.3 | chr21:46317682-46317694 | GGGCACGTGGCT | - | 6.18 | | NR2F1 | MA0017.2 | chr21:46318261-46318274 | CCTTTGACCTTTG | - | 7.22 | | ZNF143 | MA0088.2 | chr21:46317463-46317479 | TACCCACGACGCACTG | + | 6.04 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09296 | chr21:46315858-46318561 | CD14 | | SE_53340 | chr21:46317125-46318305 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr21 | 46317647 | 46318022 | | chr21 | 46317543 | 46317997 | | chr21 | 46318116 | 46318325 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH21I044897 | chr21 | 46317141 | 46318155 |
|
Enhancer Sequence | GATGAGGATA ATCGGGCCCT TTAGGGCGGC TGCTCTGTGA ATTCCCTGAG TGGGTGAGCT 60
CAGTACCCAC GACGCACTGC CCGCCGGGCA CCACTACCCC TTTCACAGAT GAGGAAACTG 120
AGGGCTCGGG GTAAGGAAGG GCCTGGGGCG TCCTGTGGTA AGTAACAGAG CTGGGTGTGA 180
GGTGAGCCAC CCAGGGCCCT GTCCACCCTG AAGAACGGGG CACGTGGCTG TGTAAAGTAC 240
AATGACAACT ATCTCGTTCC TCCAGCTCCA CCCTGAAGAA CGGGGCACGT GGCTGTGTAA 300
AGTACAATGA CAACCACCTC CTTCCTCCAG CTCAGTCCTT CTGTCCCTGT GGCCTCAGGG 360
CCACACACTG TGCAGGCTGC TATGGGCGGA GGCTCCTTTC AGGAGGGCGT GCAGTGTTTC 420
CTTCCTTCTA GCGAATCCCT GTTACACAGT CAGGGCTCCA CCCAGCAGGC CTGGCTGGCC 480
ACACCCCACA CATGCCAAAG AGTGGTAGAC CCCGGCTGAG CTCCTGAGAG GTAGCCTCTG 540
AGCCCTTGGT ACATCCTACC CGATGGGGGT GTCATTGTTC CTGGGGCCTC AGGTCACACC 600
GGATAGTCCC ACAGTGTGAT TTGGGGTGGG GCCCTGGACA GTTTTCAGCT TGACCTCTGG 660
AGGGCTAGAG ACTGAGGTCA GCCATGGGGT GTCAGCCGCG CCGCTGTGAC TGACCCCCAG 720
TAGACACCGA GGCTCAAGAG CCTCCTTGGG GACCATGTTC TGTGCATGAG GCCACACATC 780
ATCGCTGGGA GGATGGAGCG CCGCCCACAC CCCTGCAGGG AGGGGACACT GGGAGCTGGT 840
GCCTGGTTTC TCTCCTGTGC ACCTTTGACC TTTGCTGACT TTTGTCTGTA TCCTCCCACC 900
TCGGGCAGCG GCTGGCACCC AGGAGGGTCG GCTCTGCAAT AAACTGTAAC TGTGAGTTTA 960
CTGGTTCCTG AGCTCTGCAA GTCCTTCCGG CAAATCACTG ATCCTGAGAA AGGTCTTGGG 1020
AACCCCAACA GCACCTGAGC GTCTTGACGC ACTGACCTGC TCAGGCTGAA CACATGGCAC 1080
TAGCAGCGGA AATGCAGGAT GAACGTGTTT CACTGGGGGC CTCTTTTTCT AGGAGCAGAG 1140
GCTGGTTATC AGCTGTGCTT CCTTCGTGAA ATTCATCCCA CTCCGCACTC CAAGCTTGTG 1200
AACGTTTTTG TGTAATTTTA TCTTCACGGA GAGTGTTGAT GTTCAAATGT ATGTGAGCAT 1260
AAAATAAGTG TGTTTCCATA AAATAAAGAA TTGTGTTGTA TTCCAGGAAA AAACAGAAAT 1320
ATCACCAATG CCAAGACATG CTGTTAACAC AGCTGAGTTT CAGGGACGGG GAGGAATTCC 1380
TCCTCCTATC GACACGCAGG CGTCCTGTCC CCGACGGGAA GCCTCGGGCT CCTCACCTAG 1440
GGGGATCCAG GACCTGGGCC GGCTGGTTGC TCACGTGCCC AGCATGCAGA GGTGGCGCTC 1500
AGACCTGCAG TGGCGCTGGG TCTGGCCTGT GGCTGAAACA TGCCCCCACC CAATGGATGC 1560
TCGGGACCCA ACAGCACTCA 1580
|
